Type 2 Diabetes Mellitus Is Associated with the Risk of Cognitive Impairment: a Meta-Analysis
- 25 Downloads
The present meta-analysis aimed to evaluate the interaction between type 2 diabetes mellitus (T2DM) and the risk of cognitive impairment. The studies that fulfilled certain inclusion criteria were selected from online databases including PubMed, Embase, and the Cochrane Library. Data extraction and quality assessment were conducted, and subgroup analysis was performed according to the study area, population sources, and types of cognitive impairment. Publication bias and sensitivity analysis were evaluated. In total, 30 studies from 25 articles, including 2 case-control studies, 9 cohort studies, and 19 cross-sectional studies, were included. Subgroup analysis showed that despite the presence of hospital-based and multi-center subgroups in the cohort studies, the association between T2DM and cognitive impairment risk was statistically significant in all other subgroups (P < 0.05). Furthermore, the sensitivity and publication bias analysis showed good stability in all enrolled studies. T2DM might be associated with the risk of cognitive impairment. Further studies on early detection and appropriate management of cognitive impairment might be required in T2DM patients of different regions.
KeywordsType 2 diabetes mellitus Cognitive impairment Meta-analysis Subgroup analysis
This work was supported by the Nanjing Medical Science and technique Development Foundation (grant number QRX17169).
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
- Bai J, Wei P, Zhao N, Xiao Y, Yang C, Zhong J, Cai Y, Li Y, Zhu Q, Cao X, Sun L, Wang B, Teng K, Ling S, Ni H, Xie M, Tan J, Wang L, Sun XM, Zhang W (2016) A study of mild cognitive impairment in veterans: role of hypertension and other confounding factors. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 23:703–715CrossRefGoogle Scholar
- Barnett JC, Bahar-Fuchs A, Cherbuin N, Herath P, Anstey KJ (2015) Interventions to prevent cognitive decline and dementia in adults without cognitive impairment: a systematic review. J Preven Alzheimers Dis 2:38Google Scholar
- Chatterjee S, Peters SA, Woodward M, Mejia Arango S, Batty GD, Beckett N, Beiser A, Borenstein AR, Crane PK, Haan M, Hassing LB, Hayden KM, Kiyohara Y, Larson EB, Li CY, Ninomiya T, Ohara T, Peters R, Russ TC, Seshadri S, Strand BH, Walker R, Xu W, Huxley RR (2016) Type 2 diabetes as a risk factor for dementia in women compared with men: a pooled analysis of 2.3 million people comprising more than 100,000 cases of dementia. Diabetes Care 39:300–307Google Scholar
- Defronzo R, Ferrannini E, Zimmet P, Alberti K (2015) International textbook of diabetes mellitusGoogle Scholar
- Kurella Tamura M, Xie D, Yaffe K, Cohen DL, Teal V, Kasner SE, Messe SR, Sehgal AR, Kusek J, DeSalvo KB, Cornish-Zirker D, Cohan J, Seliger SL, Chertow GM, Go AS (2011) Vascular risk factors and cognitive impairment in chronic kidney disease: the Chronic Renal Insufficiency Cohort (CRIC) study. Clin J Am Soc Nephrol 6:248–256CrossRefGoogle Scholar
- Luchsinger JA, Reitz C, Patel B, Tang MX, Manly JJ, Mayeux R (2006) Relation of diabetes to mild cognitive impairment. Arch Neurol 2:570–575Google Scholar
- Mansur RB, Lee Y, Zhou AJ, Carmona NE, Cha DS, Rosenblat JD, Bruins R, Kakar R, Rasgon NL, Lovshin JA, Wroolie TE, Sim K, Brietzke E, Gerstein HC, Rong C, McIntyre R (2018) Determinants of cognitive function in individuals with type 2 diabetes mellitus: a meta-analysis. Ann Clin Psychiatry 30:38–50Google Scholar
- Rostom A, Dube C, Cranney A et al. (2004) Celiac disease. Agency for Healthcare Research and Quality (US), Rockville (MD). Appendix D. Quality Assessment. http://www.ncbi.nlm.nih.gov/books/NBK35156/?report=classic
- Saito S, Ohi T (2018) Association between tooth loss and cognitive impairment in community-dwelling older Japanese adults: a 4-year prospective cohort study from the Ohasama study. Sci Rep 18:142Google Scholar
- Shaik MA, Chan QL, Xu J, Xu X, Hui RJY, Chong SST, Chen CLH, Dong YH (2016) Risk factors of cognitive impairment and brief cognitive tests to predict cognitive performance determined by a formal neuropsychological evaluation of primary health care patients. J Am Med Dir Assoc 17:343–347CrossRefGoogle Scholar
- Wells GA, Shea BJ, O'Connell D et al (2014) The Newcastle–Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analysis. Appl Eng Agric 18:727–734Google Scholar
- Wu Y, Duan H, Chen X (2018) Effectiveness of cognitive behavioral therapy on depression and glycemic control in patients with diabetes mellitus: a meta-analysis. J Nurs SciGoogle Scholar